[go: up one dir, main page]

DK1425389T3 - Interleukin-15-(IL-15)-specifikke humane antistoffer - Google Patents

Interleukin-15-(IL-15)-specifikke humane antistoffer

Info

Publication number
DK1425389T3
DK1425389T3 DK02796411.3T DK02796411T DK1425389T3 DK 1425389 T3 DK1425389 T3 DK 1425389T3 DK 02796411 T DK02796411 T DK 02796411T DK 1425389 T3 DK1425389 T3 DK 1425389T3
Authority
DK
Denmark
Prior art keywords
human
antibodies
human antibodies
interleukin
specific human
Prior art date
Application number
DK02796411.3T
Other languages
English (en)
Inventor
De Winkel Jan G J Van
Dijk Marcus Antonius Van
Janine Schuurman
Arnout F Gerritsen
Ole Baadsgaard
Original Assignee
Genmab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmab As filed Critical Genmab As
Application granted granted Critical
Publication of DK1425389T3 publication Critical patent/DK1425389T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02796411.3T 2001-08-23 2002-08-23 Interleukin-15-(IL-15)-specifikke humane antistoffer DK1425389T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31473101P 2001-08-23 2001-08-23
PCT/US2002/026769 WO2003017935A2 (en) 2001-08-23 2002-08-23 Human antibodies specific for interleukin 15 (il-15)

Publications (1)

Publication Number Publication Date
DK1425389T3 true DK1425389T3 (da) 2012-01-30

Family

ID=23221192

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02796411.3T DK1425389T3 (da) 2001-08-23 2002-08-23 Interleukin-15-(IL-15)-specifikke humane antistoffer

Country Status (25)

Country Link
US (1) US7153507B2 (da)
EP (1) EP1425389B1 (da)
JP (2) JP4359503B2 (da)
KR (1) KR100911951B1 (da)
CN (1) CN100557018C (da)
AT (1) ATE531390T1 (da)
AU (1) AU2002332628B2 (da)
BR (1) BR0212136A (da)
CA (1) CA2456648C (da)
CY (1) CY1112447T1 (da)
DK (1) DK1425389T3 (da)
EA (1) EA014802B1 (da)
ES (1) ES2375271T3 (da)
HK (1) HK1066828A1 (da)
HU (1) HU229776B1 (da)
IL (2) IL160358A0 (da)
MX (1) MXPA04001486A (da)
NO (1) NO333152B1 (da)
NZ (1) NZ531211A (da)
PL (1) PL217752B1 (da)
PT (1) PT1425389E (da)
RS (1) RS51829B (da)
SI (1) SI1425389T1 (da)
WO (1) WO2003017935A2 (da)
ZA (1) ZA200401144B (da)

Families Citing this family (273)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2868614A1 (en) 2001-06-08 2002-12-08 Abbott Laboratories (Bermuda) Ltd. Methods of administering anti-tnf.alpha. antibodies
PL217752B1 (pl) 2001-08-23 2014-08-29 Genmab As Izolowane ludzkie przeciwciało monoklonalne wobec IL-15 lub jego fragment wiążący antygen i związane z nimi hybrydoma, kompozycja farmaceutyczna oraz zastosowania medyczne
US7247304B2 (en) 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US7329405B2 (en) 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
GB0208817D0 (en) * 2002-04-17 2002-05-29 European Molecular Biology Lab Embl Method for producing monoclonal antibodies
CN1780856A (zh) * 2003-02-26 2006-05-31 根马布股份公司 白介素15(il－15)的特异性人抗体
NZ570709A (en) 2003-06-13 2010-04-30 Univ Pennsylvania Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
US20050123542A1 (en) * 2003-11-06 2005-06-09 Genmab A/S Methods for treating disorders involving monocytes
RU2007118954A (ru) * 2004-10-22 2008-11-27 Эмджен Инк. (Us) Способ рефолдинга рекомбинантных антител
BRPI0519026A2 (pt) * 2004-12-13 2008-12-23 Cytos Biotechnology Ag arranjos de antÍgeno de il-15 e usos dos mesmos
CA2608728A1 (en) * 2005-05-16 2006-11-23 Abbott Biotechnology Ltd. Use of tnfa inhibitor for treatment of erosive polyarthritis
EP3673919A1 (en) 2005-06-14 2020-07-01 Amgen Inc. Self-buffering protein formulations
US20070190057A1 (en) * 2006-01-23 2007-08-16 Jian Wu Methods for modulating mannose content of recombinant proteins
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
WO2007120656A2 (en) * 2006-04-10 2007-10-25 Abbott Biotechnology Ltd. Uses and compositions for treatment of rheumatoid arthritis
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
WO2008100805A2 (en) 2007-02-09 2008-08-21 Genentech, Inc. Anti-robo4 antibodies and uses therefor
WO2008154543A2 (en) 2007-06-11 2008-12-18 Abbott Biotechnology Ltd. Methods for treating juvenile idiopathic arthritis
US20110097318A1 (en) * 2007-08-31 2011-04-28 Amgen Inc. Solid-State Protein Formulation
EP2197911A2 (en) * 2007-09-14 2010-06-23 Amgen Inc. Homogeneous antibody populations
US8383114B2 (en) 2007-09-27 2013-02-26 Amgen Inc. Pharmaceutical formulations
EP3381445B1 (en) 2007-11-15 2023-10-25 Amgen Inc. Aqueous formulation of antibody stablised by antioxidants for parenteral administration
TWI468417B (zh) 2007-11-30 2015-01-11 Genentech Inc 抗－ｖｅｇｆ抗體
EP2098536A1 (en) 2008-03-05 2009-09-09 4-Antibody AG Isolation and identification of antigen- or ligand-specific binding proteins
MX2010010503A (es) * 2008-03-24 2010-11-09 Abbott Biotech Ltd Metodos y composiciones para tratar perdida osea.
CU23716A1 (es) 2008-09-30 2011-10-05 Ct Ingenieria Genetica Biotech Péptido antagonista de la actividad de la interleucina-15
UA109633C2 (uk) 2008-12-09 2015-09-25 Антитіло людини проти тканинного фактора
AR077595A1 (es) 2009-07-27 2011-09-07 Genentech Inc Tratamientos de combinacion
ES2599076T3 (es) 2009-09-02 2017-01-31 Genentech, Inc. Smoothened mutante y métodos de utilización del mismo
MX344382B (es) 2009-10-23 2016-12-14 Amgen Inc * Adaptador de vial y sistema.
JP5818805B2 (ja) 2009-12-11 2015-11-18 ジェネンテック， インコーポレイテッド 抗ｖｅｇｆ−ｃ抗体及びその使用方法
EP3616719A1 (en) 2009-12-21 2020-03-04 F. Hoffmann-La Roche AG Antibody formulation
ES2545411T5 (es) 2010-06-07 2024-04-05 Amgen Inc Dispositivo de administración de fármaco
SI2580243T1 (sl) 2010-06-09 2020-02-28 Genmab A/S Protitelesa proti humanemu CD38
EP3281956A3 (en) 2010-06-15 2018-04-18 Genmab A/S Human antibody drug conjugates against tissue factor
DK2625197T3 (da) 2010-10-05 2016-10-03 Genentech Inc Smoothened-mutant og fremgangsmåder til anvendelse af samme
EP2691065B1 (en) 2011-03-31 2017-03-01 Amgen Inc. Vial adapter and system
SI2699293T1 (sl) 2011-04-20 2019-05-31 Amgen Inc. Avtoinjekcijski aparat
CN102250243B (zh) * 2011-07-01 2013-08-28 华绍炳 抗白细胞介素-15抗体
PT2734538T (pt) * 2011-07-18 2018-08-02 Iba Gmbh Processo para corar, de forma reversível, uma célula-alvo
CN103930142B (zh) 2011-10-14 2016-12-14 安姆根有限公司 注射器和装配方法
JP2015535464A (ja) 2012-11-21 2015-12-14 アムジエン・インコーポレーテツド 薬剤送達装置
WO2014128221A1 (en) 2013-02-20 2014-08-28 Innate Pharma A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphoma
SG11201507043SA (en) 2013-03-13 2015-10-29 Genentech Inc Formulations with reduced oxidation
RU2019137020A (ru) 2013-03-13 2021-01-14 Дженентек, Инк. Составы со сниженным окислением
US20140314778A1 (en) 2013-03-13 2014-10-23 Genentech, Inc. Formulations with reduced oxidation
AR095399A1 (es) 2013-03-13 2015-10-14 Genentech Inc Formulaciones con oxidación reducida, método
AU2014243783B2 (en) 2013-03-13 2018-12-13 Genentech, Inc. Antibody formulations
EP2968760B1 (en) 2013-03-15 2024-01-03 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
CA2904661C (en) 2013-03-15 2022-03-15 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
CN105121628B (zh) 2013-03-15 2020-03-24 豪夫迈·罗氏有限公司 具有抗氧化剂的细胞培养组合物和多肽生产方法
SG11201507417RA (en) 2013-03-15 2015-10-29 Amgen Inc Body contour adaptable autoinjector device
WO2014149357A1 (en) 2013-03-22 2014-09-25 Amgen Inc. Injector and method of assembly
LT3049441T (lt) 2013-09-27 2020-02-10 F. Hoffmann-La Roche Ag Anti-pdl1 antikūnų kompozicija
EP3957345A1 (en) 2013-10-24 2022-02-23 Amgen, Inc Drug delivery system with temperature-sensitive control
WO2015061386A1 (en) 2013-10-24 2015-04-30 Amgen Inc. Injector and method of assembly
CA2931812A1 (en) 2013-12-17 2015-06-25 Genentech, Inc. Methods of treating cancers using pd-1 axis binding antagonists and taxanes
EP3083687A2 (en) 2013-12-17 2016-10-26 F. Hoffmann-La Roche AG Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
KR20160089532A (ko) 2013-12-17 2016-07-27 제넨테크, 인크. Pd-1 축 결합 길항제 및 항-cd20 항체를 사용하여 암을 치료하는 방법
EP3102197B1 (en) 2014-02-04 2018-08-29 Genentech, Inc. Mutant smoothened and methods of using the same
US10994112B2 (en) 2014-02-05 2021-05-04 Amgen Inc. Drug delivery system with electromagnetic field generator
MX2016012779A (es) 2014-03-31 2017-04-27 Genentech Inc Terapia de combinacion con agentes antiangiogénesis y agonistas de unión a ox40.
KR102496507B1 (ko) 2014-05-07 2023-02-03 암겐 인코포레이티드 충격 감소 요소들을 가진 자동 주사기
MX2016015851A (es) 2014-06-03 2017-07-19 Amgen Inc Sistemas y metodos para procesar de manera remota datos recolectados por un dispositivo de suministro de farmaco.
EP2963057A1 (en) 2014-07-02 2016-01-06 Calypso Biotech SA Antibodies to IL-15
JP7072384B2 (ja) 2014-09-15 2022-05-20 ジェネンテック， インコーポレイテッド 抗体製剤
AU2015332557B2 (en) 2014-10-14 2020-05-14 Amgen Inc. Drug injection device with visual and audio indicators
EP3909611B1 (en) 2014-10-23 2023-08-30 Amgen Inc. Reducing viscosity of pharmaceutical formulations
CN106999583A (zh) 2014-11-17 2017-08-01 豪夫迈·罗氏有限公司 包含ox40结合激动剂和pd‑1轴结合拮抗剂的组合疗法
WO2016100781A1 (en) 2014-12-19 2016-06-23 Amgen Inc. Drug delivery device with proximity sensor
JP2017538512A (ja) 2014-12-19 2017-12-28 アムジエン・インコーポレーテツド ライブボタンまたはユーザインタフェースフィールドを含む薬物送達装置
JP2018512597A (ja) 2015-02-04 2018-05-17 ジェネンテック， インコーポレイテッド 突然変異体スムースンド及びその使用方法
US10583245B2 (en) 2015-02-17 2020-03-10 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
EP3261690B1 (en) 2015-02-27 2021-12-15 Amgen Inc. Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
CA2986263A1 (en) 2015-06-17 2016-12-22 Genentech, Inc. Methods of treating locally advanced or metastatic breast cancers using pd-1 axis binding antagonists and taxanes
JOP20200312A1 (ar) 2015-06-26 2017-06-16 Novartis Ag الأجسام المضادة للعامل xi وطرق الاستخدام
TWI797060B (zh) 2015-08-04 2023-04-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
JP6889149B2 (ja) 2015-08-13 2021-06-18 アムジエン・インコーポレーテツド 抗原結合タンパク質の荷電深層ろ過
WO2017039786A1 (en) 2015-09-02 2017-03-09 Amgen Inc. Syringe assembly adapter for a syringe
US11351308B2 (en) 2015-12-09 2022-06-07 Amgen Inc. Auto-injector with signaling cap
JP7046814B2 (ja) 2015-12-30 2022-04-04 ジェネンテック， インコーポレイテッド タンパク質製剤のためのトリプトファン誘導体の使用
EP3397287A1 (en) 2015-12-30 2018-11-07 Genentech, Inc. Formulations with reduced degradation of polysorbate
WO2017120178A1 (en) 2016-01-06 2017-07-13 Amgen Inc. Auto-injector with signaling electronics
AR107303A1 (es) 2016-01-08 2018-04-18 Hoffmann La Roche Métodos de tratamiento de cánceres positivos para ace utilizando antagonistas de unión a eje pd-1 y anticuerpos biespecíficos anti-ace / anti-cd3, uso, composición, kit
AU2017213826A1 (en) 2016-02-04 2018-08-23 Curis, Inc. Mutant smoothened and methods of using the same
EP3429663B1 (en) 2016-03-15 2020-07-15 Amgen Inc. Reducing probability of glass breakage in drug delivery devices
CA3016552A1 (en) 2016-03-15 2017-09-21 Genentech, Inc. Methods of treating cancers using pd-1 axis binding antagonists and anti-gpc3 antibodies
WO2017189089A1 (en) 2016-04-29 2017-11-02 Amgen Inc. Drug delivery device with messaging label
US11389588B2 (en) 2016-05-02 2022-07-19 Amgen Inc. Syringe adapter and guide for filling an on-body injector
EP3455142B1 (en) 2016-05-13 2023-08-09 Amgen Inc. Vial sleeve assembly
WO2017200989A1 (en) 2016-05-16 2017-11-23 Amgen Inc. Data encryption in medical devices with limited computational capability
TW201802121A (zh) 2016-05-25 2018-01-16 諾華公司 抗因子XI/XIa抗體之逆轉結合劑及其用途
US11541176B2 (en) 2016-06-03 2023-01-03 Amgen Inc. Impact testing apparatuses and methods for drug delivery devices
US20180002417A1 (en) 2016-06-15 2018-01-04 Celimmune Llc Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
US11285266B2 (en) 2016-07-01 2022-03-29 Amgen Inc. Drug delivery device having minimized risk of component fracture upon impact events
WO2018029124A1 (en) 2016-08-08 2018-02-15 F. Hoffmann-La Roche Ag Therapeutic and diagnostic methods for cancer
US20190328965A1 (en) 2016-08-17 2019-10-31 Amgen Inc. Drug delivery device with placement detection
MA46466A (fr) 2016-10-06 2019-08-14 Amgen Inc Formulations pharmaceutiques de protéines à viscosité réduite
WO2018075818A1 (en) * 2016-10-21 2018-04-26 Amgen Inc. Pharmaceutical formulations and methods of making the same
US20200261643A1 (en) 2016-10-25 2020-08-20 Amgen Inc. On-body injector
US11267883B2 (en) * 2016-12-21 2022-03-08 Cephalon, Inc. Antibodies that specifically bind to human IL-15 and uses thereof
JP7139332B2 (ja) 2016-12-23 2022-09-20 ノバルティス アーゲー 第ｘｉ因子抗体および使用方法
CA3049780A1 (en) 2017-01-17 2018-07-26 Amgen Inc. Injection devices and related methods of use and assembly
CA3048520A1 (en) 2017-02-17 2018-08-23 Amgen Inc. Drug delivery device with sterile fluid flowpath and related method of assembly
MX2019009755A (es) 2017-02-17 2019-10-07 Amgen Inc Mecanismo de insercion para dispositivo de suministro de farmacos.
JP2020508803A (ja) 2017-03-06 2020-03-26 アムジエン・インコーポレーテツド 作動防止特徴部を備える薬物送達デバイス
KR102627069B1 (ko) 2017-03-07 2024-01-18 암겐 인코포레이티드 과압에 의한 바늘 삽입
MX2019010671A (es) 2017-03-09 2019-10-21 Amgen Inc Mecanismo de insercion para dispositivo de administracion de farmacos.
FI3600491T3 (fi) 2017-03-28 2023-10-20 Amgen Inc Männänvarren ja ruiskukokoonpanon järjestelmä ja menetelmä
AU2018257917B2 (en) 2017-04-24 2023-05-04 University Of Massachusetts Diagnosis and treatment of vitiligo
AU2018258676B2 (en) 2017-04-28 2024-09-19 Amgen Inc. N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
EP3634546A1 (en) 2017-06-08 2020-04-15 Amgen Inc. Torque driven drug delivery device
US11590294B2 (en) 2017-06-08 2023-02-28 Amgen Inc. Syringe assembly for a drug delivery device and method of assembly
US11541183B2 (en) 2017-06-22 2023-01-03 Amgen Inc. Device activation impact/shock reduction
MX2019015479A (es) 2017-06-23 2020-02-20 Amgen Inc Dispositivo electronico de administracion de farmacos con tapa accionada por un conjunto de conmutador.
ES2972207T3 (es) 2017-07-14 2024-06-11 Amgen Inc Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble
US11672733B2 (en) 2017-07-21 2023-06-13 Amgen Inc. Gas permeable sealing member for drug container and methods of assembly
MA49677A (fr) 2017-07-25 2021-04-21 Amgen Inc Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
WO2019022950A1 (en) 2017-07-25 2019-01-31 Amgen Inc. DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
JP7237022B2 (ja) 2017-08-01 2023-03-10 アムジエン・インコーポレーテツド 質量分析法による分析用ポリペプチド試料のリアルタイム調製のためのシステム及び方法
MX2020001171A (es) 2017-08-01 2020-03-12 Amgen Inc Sistemas y metodos para realizar un ensayo de glicanos en tiempo real de una muestra.
MA49838A (fr) 2017-08-09 2020-06-17 Amgen Inc Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
MA49897A (fr) 2017-08-18 2020-06-24 Amgen Inc Injecteur sur-corps avec patch adhésif stérile
US11103636B2 (en) 2017-08-22 2021-08-31 Amgen Inc. Needle insertion mechanism for drug delivery device
EP3691717B1 (en) 2017-10-04 2023-02-08 Amgen Inc. Flow adapter for drug delivery device
EP3691716B1 (en) 2017-10-06 2023-11-29 Amgen Inc. Drug delivery device with interlock assembly and related method of assembly
US11464903B2 (en) 2017-10-09 2022-10-11 Amgen Inc. Drug delivery device with drive assembly and related method of assembly
IL273663B1 (en) 2017-11-03 2025-01-01 Amgen Inc System and methods for disinfecting a drug delivery device
ES2994389T3 (en) 2017-11-06 2025-01-23 Amgen Inc Drug delivery device with placement and flow sensing
MA50569A (fr) 2017-11-06 2020-09-16 Amgen Inc Ensembles de remplissage-finition et procédés associés
CA3079665A1 (en) 2017-11-10 2019-05-16 Amgen Inc. Plungers for drug delivery devices
JP2021503311A (ja) 2017-11-16 2021-02-12 アムジエン・インコーポレーテツド 失速及び終点検出を有するオートインジェクタ
EP3710090A1 (en) 2017-11-16 2020-09-23 Amgen Inc. Door latch mechanism for drug delivery device
US11766519B2 (en) 2018-01-17 2023-09-26 Amgen Inc. Drug delivery mechanism
WO2019173026A1 (en) 2018-03-07 2019-09-12 Amgen Inc. Controlled dispense syringe
US11890450B2 (en) 2018-03-09 2024-02-06 Amgen Inc. Backflow prevention mechanism for drug delivery device
WO2019178151A1 (en) 2018-03-13 2019-09-19 Amgen Inc. Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
US20210255075A1 (en) 2018-03-13 2021-08-19 Amgen Inc. Sequential digestion of polypeptides for mass spectrometric analysis
PL3775857T3 (pl) 2018-03-30 2024-01-29 Amgen Inc. Sprawdzanie pojemnika na lek z wykorzystaniem kamery
US11583633B2 (en) 2018-04-03 2023-02-21 Amgen Inc. Systems and methods for delayed drug delivery
US10835685B2 (en) 2018-05-30 2020-11-17 Amgen Inc. Thermal spring release mechanism for a drug delivery device
US11083840B2 (en) 2018-06-01 2021-08-10 Amgen Inc. Modular fluid path assemblies for drug delivery devices
KR20210024550A (ko) 2018-06-23 2021-03-05 제넨테크, 인크. Pd-1 축 결합 길항제, 백금 제제, 및 토포이소머라제 ii 억제제를 이용한 폐암 치료 방법
US20200171146A1 (en) 2018-07-18 2020-06-04 Genentech, Inc. Methods of treating lung cancer with a pd-1 axis binding antagonist, an antimetabolite, and a platinum agent
CA3103682A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Delivery devices for administering drugs
WO2020023220A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
WO2020023444A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Delivery devices for administering drugs
WO2020023336A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with grip portion
WO2020028009A1 (en) 2018-07-31 2020-02-06 Amgen Inc. Fluid path assembly for a drug delivery device
SG11202100601TA (en) 2018-08-08 2021-02-25 Genentech Inc Use of tryptophan derivatives and l-methionine for protein formulation
AU2019321678B2 (en) 2018-08-17 2024-11-07 Amgen Inc. Activation mechanism for drug delivery device
MX2021003213A (es) 2018-09-21 2021-05-12 Genentech Inc Metodos de diagnostico para cancer de mama triple negativo.
US20210346601A1 (en) 2018-09-24 2021-11-11 Amgen Inc. Interventional dosing systems and methods
MA53718A (fr) 2018-09-28 2022-01-05 Amgen Inc Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
CN112805048B (zh) 2018-10-02 2023-09-22 安进公司 具有内部力传递的用于药物递送的注射系统
WO2020072846A1 (en) 2018-10-05 2020-04-09 Amgen Inc. Drug delivery device having dose indicator
US12053617B2 (en) 2018-10-15 2024-08-06 Amgen Inc. Drug delivery device having damping mechanism
US20210346596A1 (en) 2018-10-15 2021-11-11 Amgen Inc. Platform assembly process for drug delivery device
TWI831847B (zh) 2018-11-01 2024-02-11 美商安進公司 部分針頭縮回之藥物遞送裝置及其操作方法
EP3873566B1 (en) 2018-11-01 2024-11-27 Amgen Inc. Drug delivery devices with partial drug delivery member retraction
IL281908B1 (en) 2018-11-01 2025-02-01 Amgen Inc Drug delivery devices with partial drug delivery unit withdrawal
AU2019396614A1 (en) 2018-12-14 2021-06-17 Amgen Inc. System suitability method for use with protein concentration determination by slope
US11534547B2 (en) 2019-01-24 2022-12-27 Amgen Inc. Drug delivery systems and methods with pressure sensitive control
EP3914320A1 (en) 2019-01-24 2021-12-01 Amgen Inc. Drug delivery systems and methods with back pressure sensing
EP3924018A1 (en) 2019-02-12 2021-12-22 Amgen Inc. Continuous dosing systems and approaches
ES2997201T3 (en) 2019-02-12 2025-02-14 Amgen Inc Take-home drug delivery system
EP3924019A1 (en) 2019-02-12 2021-12-22 Amgen Inc. Continuous dosing systems and approaches
US20220087901A1 (en) 2019-02-12 2022-03-24 Amgen Inc. Systems and approaches for drug delivery device reconstitution
US20200253823A1 (en) 2019-02-12 2020-08-13 Amgen Inc. Dosing systems and approaches
US20220096747A1 (en) 2019-02-12 2022-03-31 Amgen Inc. Continuous dosing systems and approaches
US20220137061A1 (en) 2019-02-14 2022-05-05 Amgen Inc. Systems And Methods For Preparing A Sample and Performing A Real-Time Assay Of The Sample
EP3928101B1 (en) 2019-02-20 2024-10-09 Amgen Inc. Methods of determining protein stability
US20230035363A1 (en) 2019-03-04 2023-02-02 Amgen Inc. In vivo reversibility of high molecular weight species
JP2022527062A (ja) 2019-03-27 2022-05-30 アムジェン インコーポレイテッド 製剤化された生物製剤製品のための、天然存在比での二次元（２ｄ）核磁気共鳴技術によって治療用タンパク質をフィンガープリントする方法
US11464706B2 (en) 2019-04-08 2022-10-11 Amgen Inc. Automated drug delivery device and container
AU2020271035A1 (en) 2019-04-09 2021-09-09 Amgen Inc. Drug delivery device with smart grip
JP7570347B2 (ja) 2019-04-17 2024-10-21 アムジエン・インコーポレーテツド オートインジェクタ用のカセット及び関連方法
AU2020263289A1 (en) 2019-04-24 2021-09-16 Amgen Inc. Syringe sterilization verification assemblies and methods
US20220152304A1 (en) 2019-04-24 2022-05-19 Amgen Inc. Injector accessories
MX2021014733A (es) 2019-06-05 2022-04-06 Amgen Inc Metodos de identificacion de atributos de proteinas terapeuticas.
JP2022536898A (ja) 2019-06-12 2022-08-22 アスクジーン・ファーマ・インコーポレイテッド 新規ｉｌ－１５プロドラッグおよびその使用方法
US20220347398A1 (en) 2019-06-20 2022-11-03 Amgen Inc. Wireless Communication Enabled Drug Delivery Device and Method
WO2021011717A1 (en) 2019-07-18 2021-01-21 Amgen Inc. Sealing arrangement for drug delivery device
US20220362474A1 (en) 2019-07-18 2022-11-17 Amgen Inc. Drug delivery device having pressurized vessel
WO2021021848A1 (en) 2019-08-01 2021-02-04 Amgen Inc. Drug delivery device with temperature measurement and related method
CA3148261A1 (en) 2019-08-23 2021-03-04 Amgen Inc. Drug delivery device with configurable needle shield engagement components and related methods
JP2022545556A (ja) 2019-09-03 2022-10-27 アムジエン・インコーポレーテツド 薬物送達用の起動可能な注入デバイス
TW202123988A (zh) 2019-09-03 2021-07-01 美商安進公司 用於藥物遞送之注入裝置及用於注入裝置之包裝物
US20220362462A1 (en) 2019-09-12 2022-11-17 Amgen Inc. Backflow Prevention Mechanism for Drug Delivery Device
JP2022548029A (ja) 2019-09-16 2022-11-16 アムジエン・インコーポレーテツド 薬物送達デバイスの外部滅菌の方法
CN114450049A (zh) 2019-09-30 2022-05-06 美国安进公司 药物递送装置
US20210093796A1 (en) 2019-09-30 2021-04-01 Amgen Inc. Drug delivery device
EP4037732A1 (en) 2019-09-30 2022-08-10 Amgen Inc. Drug delivery device
JP2022549883A (ja) 2019-09-30 2022-11-29 アムジエン・インコーポレーテツド 薬物送達デバイス
JP2022549687A (ja) 2019-09-30 2022-11-28 アムジエン・インコーポレーテツド 薬物送達デバイス
MX2022003292A (es) 2019-09-30 2022-04-12 Amgen Inc Dispositivo de administracion de farmacos y metodos de administracion de un farmaco.
WO2021071763A1 (en) 2019-10-07 2021-04-15 Amgen Inc. Needle insertion mechanism for drug delivery device
WO2021071831A1 (en) 2019-10-07 2021-04-15 Amgen Inc. Packages for pharmaceutical products and methods of assembly
WO2021071780A1 (en) 2019-10-07 2021-04-15 Amgen Inc. Drug delivery devices having light-activated ultrasonic fluid delivery
US20220362484A1 (en) 2019-10-07 2022-11-17 Amgen Inc. Drug delivery device
JP2022552239A (ja) 2019-10-08 2022-12-15 アムジエン・インコーポレーテツド オートインジェクタ用のカセット及び関連方法
EP4041341A1 (en) 2019-10-08 2022-08-17 Amgen Inc. Needle insertion mechanism for drug delivery device
WO2021071886A1 (en) 2019-10-08 2021-04-15 Amgen Inc. Drug delivery device
EP4041344A1 (en) 2019-10-08 2022-08-17 Amgen Inc. Temperature indicator for drug delivery device
EP4045108A1 (en) 2019-10-18 2022-08-24 Amgen Inc. Drug delivery device and system
AU2020366423A1 (en) 2019-10-18 2022-04-14 Amgen Inc. Systems and approaches for drug delivery device reconstitution
US20240091440A1 (en) 2019-10-18 2024-03-21 Amgen Inc. Drug delivery device and system
US20220331203A1 (en) 2019-10-18 2022-10-20 Amgen Inc. Systems and approaches for drug delivery device reconstitution
WO2021080828A1 (en) 2019-10-21 2021-04-29 Amgen Inc. Drug product container and drug delivery system
WO2021081283A1 (en) 2019-10-24 2021-04-29 Amgen Inc. Drug delivery device
MX2022004943A (es) 2019-10-24 2022-05-16 Amgen Inc Sistemas y enfoques para la administracion de farmacos.
EP4048345A1 (en) 2019-10-24 2022-08-31 Amgen, Inc Drug delivery device and system
US20220387700A1 (en) 2019-10-24 2022-12-08 Amgen Inc. Systems and methods for drug delivery
WO2021081161A1 (en) 2019-10-24 2021-04-29 Amgen Inc. Systems and components for drug delivery and components for preparation of the same
US20220395635A1 (en) 2019-11-07 2022-12-15 Amgen Inc. Drug delivery system and method of use
US20230001099A1 (en) 2019-12-02 2023-01-05 Amgen Inc. Lockout mechanism for drug delivery device
US20230347075A1 (en) 2019-12-05 2023-11-02 Amgen Inc. Flow restrictor for drug delivery device
AU2021205981A1 (en) 2020-01-11 2022-07-14 AskGene Pharma, Inc. Novel masked cytokines and methods of use thereof
US20210213210A1 (en) 2020-01-13 2021-07-15 Amgen Inc. Needle shield removers, drug delivery devices, and related methods
JP2023514325A (ja) 2020-02-24 2023-04-05 アムジエン・インコーポレーテツド 薬物送達デバイスの外部滅菌中に使用するための容器及びシステム
US20230173198A1 (en) 2020-03-16 2023-06-08 Amgen Inc. Drug delivery member insertion sensing assemblies, drug delivery devices, and related methods
WO2021188224A1 (en) 2020-03-17 2021-09-23 Amgen Inc. Controlled dispense syringe
WO2021221845A1 (en) 2020-04-28 2021-11-04 Amgen Inc. Packaging label
JP2023527282A (ja) 2020-05-22 2023-06-28 アムジエン・インコーポレーテツド 保管システム並びに薬剤を保管及び輸送する方法
AU2021293038A1 (en) 2020-06-16 2023-02-02 F. Hoffmann-La Roche Ag Methods and compositions for treating triple-negative breast cancer
EP4208391A1 (en) 2020-09-02 2023-07-12 Amgen Inc. Easy open apparatus for medicament storage carton
US20230302264A1 (en) 2020-09-09 2023-09-28 Amgen Inc. Swallowable drug delivery devices
WO2022055761A1 (en) 2020-09-11 2022-03-17 Amgen Inc. Inline uv flow device for sterilizing flow cytometry sheath fluid
JP2023543167A (ja) 2020-09-18 2023-10-13 アムジエン・インコーポレーテツド ペプチドマッピング分析のための試料を処理する方法
JP2023545425A (ja) 2020-10-12 2023-10-30 アムジエン・インコーポレーテツド 長期薬剤保管装置及び方法
MX2023005061A (es) 2020-11-04 2023-05-12 Amgen Inc Ensamblaje de dispositivo de administracion de farmacos y accesorio para dispositivo de administracion de farmacos.
AU2021374583A1 (en) 2020-11-04 2023-04-20 Amgen Inc. Drug delivery device assembly and accessory for drug delivery device
US20230381426A1 (en) 2020-11-04 2023-11-30 Amgen Inc. Drug delivery device assembly and accessory for drug delivery device
JP2023549083A (ja) 2020-11-04 2023-11-22 アムジエン・インコーポレーテツド 薬物送達デバイスアセンブリ及び薬物送達デバイス用アクセサリ
MX2023005320A (es) 2020-11-05 2023-05-19 Amgen Inc Materiales y metodos para el procesamiento de proteinas.
EP4288197A1 (en) 2021-02-03 2023-12-13 Amgen Inc. Systems and approaches for drug processing
US20240115462A1 (en) 2021-02-03 2024-04-11 Amgen Inc. High-throughput automated reconstitution of lyophilized drug product
US20240082110A1 (en) 2021-02-03 2024-03-14 Amgen Inc. Coaxial needle adapter and guide bracket for robotic liquid handling platform
TW202241532A (zh) 2021-03-08 2022-11-01 美商安進公司 中空柱塞桿之製造製程
BR112023018234A2 (pt) 2021-03-10 2023-10-24 Amgen Inc Dispositivo de administração de fármaco tendo uma tampa removível
MX2023010440A (es) 2021-03-10 2023-09-12 Amgen Inc Dispositivo de administracion de farmacos, subconjunto para dispositivo de administracion de farmacos, soporte de jeringa y metodo de ensamblado.
US20220288324A1 (en) 2021-03-10 2022-09-15 Amgen Inc. Drug delivery device
BR112023019565A2 (pt) 2021-03-25 2023-11-14 Amgen Inc Dispositivo de administração de fármacos
EP4313214A1 (en) 2021-03-31 2024-02-07 Amgen Inc. Sound-detection based injection time measurement system for drug delivery devices
WO2022225736A1 (en) 2021-04-22 2022-10-27 Amgen Inc. Methods and systems for automated syringe quality evaluation
AU2022266655A1 (en) 2021-04-28 2023-09-21 Amgen Inc. Systems for out-patient treatment of a patient, and related methods
US20240257936A1 (en) 2021-05-17 2024-08-01 Amgen Inc. Feedback system and method for a drug product
WO2022246055A1 (en) 2021-05-21 2022-11-24 Amgen Inc. Method of optimizing a filling recipe for a drug container
WO2022256199A1 (en) 2021-06-01 2022-12-08 Amgen Inc. Lyophilization system
WO2022260925A1 (en) 2021-06-08 2022-12-15 Amgen Inc. Drug delivery devices, finger-grip elements, and related methods
TW202310885A (zh) 2021-06-17 2023-03-16 美商安進公司 具有減震器的藥物遞送裝置
EP4359036A1 (en) 2021-06-23 2024-05-01 Amgen Inc. Syringes, assemblies, and methods of manufacture
WO2023278125A1 (en) 2021-06-28 2023-01-05 Amgen Inc. Safety device for drug delivery system
WO2023287562A1 (en) 2021-07-16 2023-01-19 Amgen Inc. Systems and approaches for drug processing single-use hardware
EP4408504A1 (en) 2021-09-29 2024-08-07 Amgen Inc. Apparatuses, systems and methods for plunger-stopper depth measurement in pre-filled syringes
MX2024003555A (es) 2021-10-06 2024-04-03 Amgen Inc Herramienta de retencion activada por impacto para dispositivo de administracion de farmacos.
AU2022361395A1 (en) 2021-10-06 2024-03-14 Amgen Inc. Impact activated brake feature for drug delivery device
EP4415780A1 (en) 2021-10-11 2024-08-21 Amgen Inc. Characterization apparatus for drug delivery devices or subcomponents thereof
TW202327677A (zh) 2021-11-05 2023-07-16 美商安進公司 藥物遞送裝置、供藥物遞送裝置內使用的部件以及操作藥物遞送裝置之方法
TW202325853A (zh) 2021-11-09 2023-07-01 美商安進公司 治療性蛋白之生產
TW202335693A (zh) 2021-11-29 2023-09-16 美商安進公司 活塞桿移除力方法及設備
US20250009976A1 (en) 2021-12-03 2025-01-09 Amgen Inc. Stopper placement in a syringe
KR20240155874A (ko) 2022-03-11 2024-10-29 암젠 인크 깊이 조정 가능한 자동 주입기
WO2023196111A1 (en) 2022-04-06 2023-10-12 Amgen Inc. Packaging for drug delivery device
WO2024028448A1 (en) 2022-08-04 2024-02-08 Calypso Biotech Sa Il-15 inhibitors useful for the treatment of atopic dermatitis
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
WO2024039575A1 (en) 2022-08-18 2024-02-22 Amgen Inc. Needle shield for syringe
AU2023324704A1 (en) 2022-08-18 2025-01-16 Amgen Inc. Needle shield assembly for a syringe
WO2024049793A1 (en) 2022-08-30 2024-03-07 Amgen Inc. System and method of limiting subvisible particles in a syringe
US20240369490A1 (en) 2023-05-01 2024-11-07 Amgen Inc. Configurable handheld biological analyzers for identification of biological products based on raman spectroscopy using ensemble artificial intelligence
WO2024259275A1 (en) 2023-06-14 2024-12-19 Bristol-Myers Squibb Company Near real time sialic acid quantitation of glycoproteins
WO2025019224A1 (en) 2023-07-14 2025-01-23 Amgen Inc. Monitoring systems and methods for injection devices
CN117209605B (zh) * 2023-11-09 2024-01-30 北京百普赛斯生物科技股份有限公司 特异性结合il-15的抗体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1690935A3 (en) * 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US6255458B1 (en) * 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
US5574138A (en) 1993-03-08 1996-11-12 Immunex Corporation Epithelium-derived T-cell factor
US5591630A (en) * 1994-05-06 1997-01-07 Immunex Corporation Monoclonal antibodies that bind interleukin-15 receptors
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
CA2217122C (en) 1995-04-02 2004-10-26 Chugai Seiyaku Kabushiki Kaisha Medical composition for curing thrombocytopenia
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
WO1997041232A1 (en) 1996-04-26 1997-11-06 Beth Israel Deaconess Medical Center Antagonists of interleukin-15
AU729515B2 (en) 1996-10-17 2001-02-01 Immunomedics Inc. Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
ES2187946T3 (es) 1997-02-21 2003-06-16 Vlaams Interuniv Inst Biotech Uso de interleucina-15.
DE69841452D1 (de) * 1997-02-28 2010-03-04 Kyowa Hakko Kirin Co Ltd Humanes Chromosomfragment und ein Vektor, der dies enthält
GB9814892D0 (en) 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
WO2001002003A1 (en) 1999-07-06 2001-01-11 Bulfone Paus Silvia Method of treating psoriasis with il-15 antagonist
PL217752B1 (pl) 2001-08-23 2014-08-29 Genmab As Izolowane ludzkie przeciwciało monoklonalne wobec IL-15 lub jego fragment wiążący antygen i związane z nimi hybrydoma, kompozycja farmaceutyczna oraz zastosowania medyczne

Also Published As

Publication number Publication date
WO2003017935A3 (en) 2003-08-14
RS51829B (sr) 2012-02-29
PL217752B1 (pl) 2014-08-29
PT1425389E (pt) 2012-02-07
HUP0402653A3 (en) 2010-01-28
CA2456648A1 (en) 2003-03-06
HK1066828A1 (en) 2005-04-01
MXPA04001486A (es) 2004-10-27
IL160358A (en) 2010-12-30
AU2002332628B2 (en) 2007-07-26
NO20040752L (no) 2004-04-24
HU229776B1 (hu) 2014-07-28
CY1112447T1 (el) 2015-12-09
NZ531211A (en) 2007-04-27
EA200400345A1 (ru) 2004-12-30
KR20040047796A (ko) 2004-06-05
KR100911951B1 (ko) 2009-08-13
CN100557018C (zh) 2009-11-04
EA014802B1 (ru) 2011-02-28
SI1425389T1 (sl) 2012-02-29
JP2005503151A (ja) 2005-02-03
BR0212136A (pt) 2004-12-07
NO333152B1 (no) 2013-03-18
CN1571836A (zh) 2005-01-26
WO2003017935A9 (en) 2003-04-10
ES2375271T3 (es) 2012-02-28
EP1425389A4 (en) 2007-08-01
JP2009256354A (ja) 2009-11-05
EP1425389B1 (en) 2011-11-02
CA2456648C (en) 2011-08-16
EP1425389A2 (en) 2004-06-09
HUP0402653A2 (hu) 2005-03-29
US20030138421A1 (en) 2003-07-24
PL371946A1 (en) 2005-07-11
YU15104A (sh) 2006-08-17
IL160358A0 (en) 2004-07-25
JP4359503B2 (ja) 2009-11-04
ATE531390T1 (de) 2011-11-15
WO2003017935A2 (en) 2003-03-06
US7153507B2 (en) 2006-12-26
ZA200401144B (en) 2005-05-12

Similar Documents

Publication Publication Date Title
LTPA2021514I1 (da)
DK1425389T3 (da) Interleukin-15-(IL-15)-specifikke humane antistoffer
TW200500378A (en) Human antibodies specific for interleukin 15 (IL-15)
ATE531731T1 (de) Humane monoklonale antikörper gegen den epidermal-growth-factor-rezeptor (egfr)
DK1210374T3 (da) Humane, monoklonale antistoffer over for prostataspecifikt membranantigen
ATE527278T1 (de) Humane monoklonale antikörper gegen interleukin 8 (il-8)
WO2003064606A3 (en) Human monoclonal antibodies to prostate specific membrane antigen (psma)
RS20050724A (en) Human antibodies specific for interleukin 15(il-15)